Sylvie Guichard

Sylvie Guichard

Company: Forma Therapeutics

Job title: Senior Director - Translational Science & Biology


A Novel CBP/p300 Inhibitor for the Treatment of AR-driven Cancers 1:30 pm

Presenting a novel CBP/p300 inhibitor which antagonizes AR signalling Analyzing the efficacy of the drug in several models of AR-driven tumors in vitro and in vivo It is currently in Ph1 clinical trial in prostate cancerRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.